Therapies for improving or enhancing insulin sensitivity will hopefully bring beneficial clinical effects on the metabolic disorders and lifestyle-related diseases including obesity and diabetes [18]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.